Browse > Article

Inhibitory Effect of D-pinitol on Both Growth and Recurrence of Breast Tumor from MDA-MB-231 Cancer Cells  

Kim, Yoon-Seob (College of Pharmacy and Medical Research Center, Chungbuk National University)
Park, Ji-Sung (College of Pharmacy and Medical Research Center, Chungbuk National University)
Kim, Minji (College of Pharmacy and Medical Research Center, Chungbuk National University)
Hwang, Bang Yeon (College of Pharmacy and Medical Research Center, Chungbuk National University)
Lee, Chong-Kil (College of Pharmacy and Medical Research Center, Chungbuk National University)
Song, Sukgil (College of Pharmacy and Medical Research Center, Chungbuk National University)
Publication Information
Korean Journal of Pharmacognosy / v.45, no.2, 2014 , pp. 174-180 More about this Journal
Abstract
D-Pinitol, an anti-diabetic substance, is a naturally occurring compound found in legumes. In this study, we investigated the inhibitory effect of D-pinitol on growth and recurrence of breast cancer. When D-pinitol was treated on MDA-MB-231 or MCF-7 breast cancer cells, it was observed that the viability of the two cancer cell lines was reduced in MTT assay. In order to examine the effect on the growth of breast tumor, mouse xenograft assay was carried out. On day 0, nine millions cells of MDA-MB-231 were injected subcutaneously into nude mouse and D-pinitol was administered orally at the dose of 500 mg/kg or 1000 mg/kg body weight for consecutive 45 days. Tumor size was reduced in dose-dependent manner upto 95.4% in 1000 mpk-treated group, compared with the non-treated control group. When D-pinitol was co-administrated with $4{\mu}g$ of doxorubicin, recurrence of breast tumor was delayed by two weeks, compared with the mouse group of doxorubicin monotherapy. Consistent with this data, it was observed that the population of cancer stem cells (CSCs), responsible for recurrence of cancer, within tumor mass was significantly reduced. Taken together, D-pinitol inhibits the growth of breast cancer and relapse of the tumor by suppressing the proliferation of CSCs.
Keywords
D-pinitol; Breast cancer; Cancer stem cells;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Ma, S., Chan, K. W., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., Zheng, B. J. and Guan, X. Y. (2007) Identification and characterisation of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132: 2542-2556.   DOI   ScienceOn
2 Fang, D., Nguyen, T. K., Leishear, K., Finko, R., Kulp, A. N., Hotz, S., Van Belle, P. A., Xu, X., Elder, D. E. and Herlyn, M. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65: 9328-9337.   DOI   ScienceOn
3 Bapat, S. A., Mali, A. M., Koppikar, C. B. and Kurrey, N. K. (2005) Stem and progenitor like cells contribute to the aggressive behaviour of human epithelial ovarian cancer. Cancer Res. 65: 3025-3029.   DOI
4 O'Brien, C. A., Pollett, A., Gallinger, S. and Dick, J. E. (2007) A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 445: 106-110.   DOI   ScienceOn
5 Ho, M. M., Ng, A. V., Lam, S. and Hung, J. Y. (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67: 4827-4833.   DOI   ScienceOn
6 Hermann, P., Huber, S., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J. and Heeschen, C. (2007) Distinct populations of cancer stem cells determine tumour growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323.   DOI   ScienceOn
7 Fukuda, K., Siakawa, Y., Ohashi, M., Kumagai, K., Kitajima, M., Okano, H., Matsuzaki, Y. and Kitagawa, Y. (2009) Tumor initiating potential of side population cells in human gastric cancer. Int. J. Oncol. 34: 1201-1207.
8 Lagadec, C., Vlashi, E., Donna, L. D., Dekmezian, C. and Pajonk, F. (2012) Radiation-induced reprogramming of breast cancer cells. Stem Cells 30: 833-844.   DOI   ScienceOn
9 Al-Hajj, M., Becker, M. W., Wicha, M., Weissman, I. and Clarke, M. F. (2004) Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14: 43-47.   DOI   ScienceOn
10 Lapidot, T., Sirard, C., Vormoor, J., Tsvee, L., Christian, A., Josef, V., Barbara, M., Trang, H., Julio, C. C., Mark, M., Bruce, P., Michael, A. C. and John, E. D. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.   DOI   ScienceOn
11 Jatoi, I., Tsimelzon, A., Weiss, H., Clark, G. M. and Hilsenbeck, S. G. (2005) Hazard rates of recurrence following diagnosis of primary breast cancer. Breast Cancer Res. Treat. 89: 173-178.   DOI   ScienceOn
12 Demicheli, R., Abbattista, A., Miceli, R., Valagussa, P. and Bonadonna, G. (1996) Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res. Treat. 41: 177-185.   DOI   ScienceOn
13 Ahmad, A. (2012) Pathway to breast cancer recurrence. ISRN Oncol. 2013: Article ID 290568, 16.
14 Bonnet, D. and Dick, J. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3: 730-737.   DOI   ScienceOn
15 Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. and Clarke, M.F. (2003) Prospective identification of tumorigenic breast cancer stem cells. Proc. Natl. Acad. Sci. 100: 3983-3988.   DOI   ScienceOn
16 Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J. and Maitland, N.J. (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65: 10946-10951.   DOI   ScienceOn
17 Narayanan, C. R., Joshi, D. D., Mudjumdar, A. M. and Dhekne, V.V. (1987) Pinitol, a new anti-diabetic compound from the leaves of Bougainvillea spectabilis. Curr. Sci. 56: 139-141.
18 Larner, J. (2002) D-chiro-inositol - its functional role in insulin action and its deficit in insulin resistance. Int. J. Exp. Diabetes Res. 3: 47-60.   DOI   ScienceOn
19 Koo, B. J., Kim, H. J. and Park, K. S. (2007) The clinical study to evaluate the safety and efficacy of D-chiro-inositol in patients with type 2 diabetes. Korean J. med. 72: 29-36.
20 Witters, L. A. (2001) The blooming of the French lilac. J. Clin. Invest. 108: 1105-1107.   DOI   ScienceOn
21 Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N. and Pollak, M. (2006) Metformin is an AMP kinase-Dependent growth inhibitor for breast cancer cells. Cancer Res. 66: 10269-10273.   DOI   ScienceOn
22 Euhus, D. M. (2001) Understanding mathematical models for breast cancer risk assessment and counseling. Breast J. 7: 224-232.   DOI   ScienceOn
23 Park, S. K., Lim, Y. K. and Yoo, K. Y. (1998) Prediction of future breast cancer mortality in Korea. Korean J. Epidemiol. 20: 267-274.
24 Park, B., Choi, K. S., Lee, Y. Y., Jun, J. K. and Seo, H. G. (2012) Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey. Asian Pac. J. Cancer Prev. 13: 1187-1191.   DOI   ScienceOn
25 Bland, K. I., Copeland, E. M. III., Breast. In: Schwartz, S. I., Shires, G. T. and Spencer, F. C. (1994) Principles of surgery, 6th ed. NewYork: McGraw-Hill 554-557.
26 Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D.H., Bronner-Fraser, M. and Kornblum, H.I. (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. 100: 15178-15183.   DOI   ScienceOn
27 Sethi, G., Ahn, K. S., Sung, B. K. and Aggarwal, B. B. (2008) Pinitol targets nuclear factor-kB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis. Mol. Cancer Ther. 7: 1604-1614.   DOI   ScienceOn
28 Thamaraiselvan, R., Natarajan, N. and Maruthaiveeran, P. B. (2013) D-pinitol prevents rat breast carcinogenesis induced by 7, 12-dimethylbenz [a] anthracene through inhibition of bcl-2 and induction of p53, caspase-3 proteins and modulation of hepatic biotransformation enzymes and antioxidants. Biomed. Prev. Nutr. 3: 31-41.   DOI
29 Ta, H. Q., Thomas, K. S., Schrecengost, R. S. and Bouton, A. H. (2008) A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells. Cancer Res. 68: 8796-8804.   DOI